Search
AI hedge fund Numerai wins backing from top university endowments, token soars
20.11.2025
Numerai’s NMR token jumped over 40% after it announced a new funding round led by major university endowments, pushing the hedge fund to a $500 million valuation
Cipher Mining Inks New 10-Year HPC Deal With Fluidstack; Shares Rise 13%
20.11.2025
The expansion adds 56 MW at Barber Lake and secures $830 million in contracted revenue, reinforced by increased Google backing
Cypherpunk Launches Zcash Treasury With $50M Backing
13.11.2025
Gemini co-founder Tyler Winklevoss launches Cypherpunk to accumulate Zcash as a privacy-focused treasury asset. Tyler Winklevoss announced the launch of Cypherpunk, a company funded with over $50 million from Winklevoss Capital to accumulate Zcash (ZEC) as a privacy and self‑sovereignty treasury...
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token